This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Ovarian Function Suppression in HR+ HER2+ Breast Cancer - Exploratory Analysis From HERA Trial

40 views
October 8, 2024
Comments 0
Login to view comments. Click here to Login